| The CS group | The control group | P value |
---|---|---|---|
Infected limbs | 20 | 28 | – |
Age (years) | 59.2 (43–76) | 61.8 (47–83) | 0.353 |
Sex (Male) | 9 | 17 | 0.416 |
Side (Left) | 9 | 11 | 0.883 |
Mean duration of DFO (weeks) | 15 (1–77) | 17 (2–257) | 0.804 |
The Texas classification system | |||
 III B | 17 | 21 | 0.631 |
 III D | 3 | 7 |  |
Hypertension | 8 | 15 | 0.465 |
Renal insufficiency | 9 | 17 | 0.635 |
Mean ankle brachial index (ABI) | 1.06 (0.82–1.43) | 0.98 (0.65–1.17) | 0.107 |
Mean WBC count (×109/L) | 8.09 (2.81–14.23) | 8.03 (3.96–12.07) | 0.936 |
Mean CRP (ng/L) | 32.90 (1.17–165.47) | 31.93 (1.20–114.40) | 0.927 |
Mean ESR (mm/h) | 86 (34–134) | 88 (30–140) | 0.829 |
Mean Albumin (g/L) | 33.3 (20.9–42.6) | 31.8 (24.7–36.9) | 0.304 |
Mean Creatinine (μmol/L) | 135 (38–682) | 113 (33–513) | 0.586 |
Mean HbA1c (%) | 8.6 (5.6–10.1) | 8.2 (4.8–11.2) | 0.768 |